PDB32 ECONOMIC AND HEALTH CONSEQUENCES OF THE USE OF A DPP4 PLUS METPHORMINE SCHEME IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN MEXICO FROM THE PRIVATE PERSPECTIVE
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72279-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)72279-8/fulltext
Section Title :
Section Order :
873
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72279-8&doi=10.1016/S1098-3015(10)72279-8